| |||||||||
Former Names FVB/N-Tg(WapTgfa)215Bri/J (Changed: 08-AUG-08 ) Type Congenic; Transgenic; Additional information on Genetically Engineered and Mutant Mice. Visit our online Nomenclature tutorial. Additional information on Congenic nomenclature. Species laboratory mouse Generation N12 Donating Investigator Eric Sandgren, Univ of Wisconsin School of Vet Med Description
Transgenic females showed precocious mammary gland development during pregnancy. Involution was delayed beyond 8 days post-parturition. With successive pregnancies hyperplastic alveolar nodules increased in number. Mammary tumors, the majority of which were well-differentiated, were observed with variable latency, on average at 7-8 months of age in multiparious females. Fibroadenomas composed of neoplastic glandular alveolar epithelium surrounded by variable amounts of stroma were also observed. Metastasis to the lung was observed in 1 of 40 tumor-bearing mice. Virgin mice were tumor-free.
| Control | ||
|---|---|---|
| Noncarrier | ||
| 001800 FVB/NJ | ||
| Considerations for Choosing Controls | ||
Strains carrying other alleles of Wap
003552 B6129-Tg(Wap-cre)11738Mam/J 002409 B6;SJL-Tg(Wap-HRAS)69Lln Chr YSJL/J 003189 C57BL/6J-Tg(WAPTAg)3Knw/J 002500 C57BL/6J-Tg(WapIgf1)39Dlr/J 003188 C57BL/6J-Tg(WapTAg)1Knw 002410 FVB.Cg-Tg(Wap-HRAS)69Lln Chr YSJL/J 003078 FVB.Cg-Tg(WapIgf1)39Dlr/J 002755 FVB/N-Tg(WapNotch4)10Rnc/J View Strains carrying other alleles of Wap (8 strains)
View Mammalian Phenotype Terms
Mammalian Phenotype Terms
assigned by genotype
Tg(WapTgfa)215Bri/0
FVB.Cg-Tg(WapTgfa)215Bri
- endocrine/exocrine gland phenotype
- abnormal mammary gland morphology (MGI Ref ID J:114568)
- apoptosis in the mammary gland are reduced prior to 12 weeks of age and increased after 16 weeks of age compared to in wild-type mice
- lobules contain more cells than in wild-type mice
- mammary ductal hyperplasia (MGI Ref ID J:114568)
- mice exhibit increased ductal cell proliferation with greater lobular development compared to in wild-type mice
- mammary gland hyperplasia (MGI Ref ID J:114568)
- cell proliferation in lobules of the mammary gland is 7-fold higher than in wild-type mice after 16 weeks of age
- unlike in wild-type mice, proliferation rates remain high as mice age
- mice exhibit increased number and size of hyperplastic areas compared to in wild-type mice
- cell proliferation of normal cells in tumor containing glands is increased compared to in non-tumor containing glands
- tumorigenesis
- mammary gland tumor (MGI Ref ID J:114568)
- tumors exhibit high cell proliferation rates similar to hyperpastic mammary gland tissue
- reproductive system phenotype
- abnormal mammary gland morphology (MGI Ref ID J:114568)
- apoptosis in the mammary gland are reduced prior to 12 weeks of age and increased after 16 weeks of age compared to in wild-type mice
- lobules contain more cells than in wild-type mice
- mammary ductal hyperplasia (MGI Ref ID J:114568)
- mice exhibit increased ductal cell proliferation with greater lobular development compared to in wild-type mice
- mammary gland hyperplasia (MGI Ref ID J:114568)
- cell proliferation in lobules of the mammary gland is 7-fold higher than in wild-type mice after 16 weeks of age
- unlike in wild-type mice, proliferation rates remain high as mice age
- mice exhibit increased number and size of hyperplastic areas compared to in wild-type mice
- cell proliferation of normal cells in tumor containing glands is increased compared to in non-tumor containing glands
The following phenotype information may relate to a genetic background differing from this JAX® Mice strain.
Tg(WapTgfa)215Bri/0
involves: C57BL/6 * SJL
- life span-post-weaning/aging
- premature death (MGI Ref ID J:56318)
- female mice die by 14 months of age
- endocrine/exocrine gland phenotype
- abnormal lactation (MGI Ref ID J:56318)
- female mice do not lactate
- abnormal mammary gland morphology (MGI Ref ID J:56318)
- female mice produce precocious small alveoli by day 14 of pregnancy unlike in wild-type mice
- abnormal involution of the mammary gland (MGI Ref ID J:56318)
- delayed
- mammary gland hyperplasia (MGI Ref ID J:56318)
- female mice exhibit precocious glandular development
- glandular hyperplasia worsens with each pregnancy resulting in the creation of numerous hyperplastic alveolar nodules resembling tumors
- tumorigenesis
- mammary gland tumor (MGI Ref ID J:56318)
- female mice develop mammary gland tumors and die by 14 months of age
- female mice develop well differentiated microcystic/glandular adenomas or carcinomas and papillary adenocarcinomas that resemble normal pregnant and lactating mammary epitherlium as well as fibroadenomas and occasionally solid carcinomas that do not resemble a normal mammary gland
- 17% of tumors are glandular/microcystic foci combined with papillary, fibroadenomatous or solid foci
- while lung metastasis is rare (in 1 of 40 mice), most tumors are transplantable
- however, virgin females do not develop mammary gland tumors
- mammary adenocarcinoma (MGI Ref ID J:56318)
- most tumors are well differentiated adenomas and adenocarcinomas
- reproductive system phenotype
- abnormal lactation (MGI Ref ID J:56318)
- female mice do not lactate
- abnormal mammary gland morphology (MGI Ref ID J:56318)
- female mice produce precocious small alveoli by day 14 of pregnancy unlike in wild-type mice
- abnormal involution of the mammary gland (MGI Ref ID J:56318)
- delayed
- mammary gland hyperplasia (MGI Ref ID J:56318)
- female mice exhibit precocious glandular development
- glandular hyperplasia worsens with each pregnancy resulting in the creation of numerous hyperplastic alveolar nodules resembling tumors
Tg(WapTgfa)215Bri/0
B6.Cg-Tg(WapTgfa)215Bri
- tumorigenesis
- lymphoma (MGI Ref ID J:123146)
- mice exhibit pulmonary foci that display perivascular lymphocytic infiltration and perivascular lymphomas of unknown origins as well as 1 metastatic adenocarcinoma
- mammary gland tumor (MGI Ref ID J:123146)
- all mice develop mammary gland tumors within 1 year with mean onset at 6 months of age and earliest onset at 12 weeks of age
- endocrine/exocrine gland phenotype
- mammary gland hyperplasia (MGI Ref ID J:123146)
- reproductive system phenotype
- mammary gland hyperplasia (MGI Ref ID J:123146)
View Research Applications
Research Applications
This mouse can be used to support research in many areas including:
Cancer Research
Increased Tumor Incidence (Mammary Gland Tumors)
| Allele Symbol | Tg(WapTgfa)215Bri | ||
|---|---|---|---|
| Allele Name | transgene insertion 215, Ralph L Brinster | ||
| Allele Type | Transgenic (random, expressed) | ||
| Mutation Made By | Ralph Brinster, University of Pennsylvania | ||
| Strain of Origin | (C57BL/6 x SJL)F2 | ||
| Expressed Gene | Tgfa, transforming growth factor alpha, rat | ||
| Promoter | Wap, whey acidic protein, mouse, laboratory | ||
| Molecular Note | The transgene contains the mouse whey acidic protein (WAP) promoter and the mouse transforming growth factor alpha (Tgfa) gene. [MGI Ref ID J:56318] | ||
Genotyping Protocols
Tg(WapTgfa)215Bri, STD PCR, vers. 1
Helpful Links
Optimizing PCR Protocols
Sandgren EP; Schroeder JA; Qui TH; Palmiter RD; Brinster RL; Lee DC. 1995. Inhibition of mammary gland involution is associated with transforming growth factor alpha but not c-myc-induced tumorigenesis in transgenic mice. Cancer Res 55(17):3915-27. [PubMed: 7641211] [MGI Ref ID J:56318]
Tg(WapTgfa)215Bri relatedPochampalli MR; Bitler BG; Schroeder JA. 2007. Transforming growth factor alpha dependent cancer progression is modulated by Muc1. Cancer Res 67(14):6591-8. [PubMed: 17638868] [MGI Ref ID J:123146]
Rose-Hellekant TA; Wentworth KM; Nikolai S; Kundel DW; Sandgren EP. 2006. Mammary Carcinogenesis Is Preceded by Altered Epithelial Cell Turnover in Transforming Growth Factor-{alpha} and c-myc Transgenic Mice. Am J Pathol 169(5):1821-32. [PubMed: 17071603] [MGI Ref ID J:114568]
Colony Maintenance
Diet Information LabDiet® 5K52/5K67
| Pricing for USA, Canada and Mexico shipping destinations |
|
Animals Provided
Price (US dollars $) Cryorecovery Fee $1900.00 At least two mice that carry the mutation (if it is a mutant strain) will be provided. Their genotypes may not reflect those discussed in the strain description. Please inquire for possible genotypes and see additional details below.
| Pricing for International shipping destinations |
|
Animals Provided
Price (US dollars $) Cryorecovery Fee $2470.00 At least two mice that carry the mutation (if it is a mutant strain) will be provided. Their genotypes may not reflect those discussed in the strain description. Please inquire for possible genotypes and see additional details below.
| Standard Supply | Cryopreserved. Ready for recovery. Please refer to pricing and supply notes for further information. |
|---|---|
| Supply Notes |
|
| Control | ||
|---|---|---|
| Noncarrier | ||
| 001800 FVB/NJ | ||
| Considerations for Choosing Controls | ||
| USA, Canada and Mexico - Control Pricing Information for Genetically Engineered Mutant Strains. | ||
| International - Control Pricing Information for Genetically Engineered Mutant Strains. | ||
Purchasing Information
JAX® Mice Orders
Surgical Services
Contact Information
Orders & Technical Support
Tel: 800.422.6423 or 207.288.5845
Fax: 207.288.6150
Technical Support Email Form
| phone: | 207-288-6470 |
| fax: | 207-288-6655 |
MICE, PRODUCTS AND SERVICES ARE PROVIDED “AS IS”. THE LABORATORY EXTENDS NO WARRANTIES OF ANY KIND, EITHER EXPRESS, IMPLIED, OR STATUTORY, WITH RESPECT TO MICE, PRODUCTS OR SERVICES, INCLUDING ANY IMPLIED WARRANTY OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE, OR ANY WARRANTY OF NON-INFRINGEMENT OF ANY PATENT, TRADEMARK, OR OTHER INTELLECTUAL PROPERTY RIGHTS.
In case of dissatisfaction for a valid reason and claimed in writing by a purchaser within ninety (90) days of receipt of MICE, products or services, The Jackson Laboratory will, at its option, provide credit or replacement for the MICE or product received or the services provided.
In no event shall The Jackson Laboratory, its trustees, directors, officers, employees, and affiliates be liable for any causes of action or damages, including any direct, indirect, special, or consequential damages, arising out of the provision of MICE, products or services, including economic damage or injury to property and lost profits, and including any damage arising from acts or negligence on the part of The Jackson Laboratory, its agents or employees. In purchasing or receiving MICE, products or services from The Jackson Laboratory, purchaser or recipient, or any party claiming by or through them, expressly releases and discharges The Jackson Laboratory from all such causes of action or damages, and further agrees to defend and indemnify The Jackson Laboratory from any costs or damages arising out of any third party claims.
MICE and biological materials are to be used in a safe manner and in accordance with all applicable governmental rules and regulations.
The foregoing represents the General Terms and Conditions applicable to The Jackson Laboratory’s MICE, products and services. In addition, special terms and conditions of sale of certain MICE, products and services may be set forth separately in The Jackson Laboratory web pages, catalogs, price lists, contracts, and/or other documents, and these special terms and conditions shall also govern the sale of these MICE, products and services by The Jackson Laboratory, and by its licensees and distributors.
Acceptance of delivery of MICE, products or services shall be deemed agreement to these terms and conditions. No purchase order or other document transmitted by purchaser or recipient that may modify the terms and conditions hereof, shall be in any way binding on The Jackson Laboratory, and instead the terms and conditions set forth herein, including any special terms and conditions set forth separately, shall govern the sale of MICE, products services by The Jackson Laboratory.